安徽贝克生物制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
25
NMPA:25
Drug Approvals
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）
- Product Name
- 依非米替片(Ⅰ)
- Approval Number
- 国药准字H20254536
- Approval Date
- Jun 10, 2025
NMPA
Levodopa and Benserazide Hydrochloride Tablets
- Product Name
- 多巴丝肼片
- Approval Number
- 国药准字H20254060
- Approval Date
- Apr 30, 2025
NMPA
Selegiline Hydrochloride Tablets
- Product Name
- 盐酸司来吉兰片
- Approval Number
- 国药准字H20234721
- Approval Date
- Mar 6, 2024
NMPA
Lopinavir and Ritonavir Tablets
- Product Name
- 洛匹那韦利托那韦片
- Approval Number
- 国药准字H20234040
- Approval Date
- Feb 26, 2024
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found